Aligos Therapeutics, Inc. (ALGS): SCHEDULE 13D/A filed Mar 12, 2025

Form type

SCHEDULE 13D/A

Filing date

Mar 12, 2025

Accession number

0000950170-25-038262

Filer

Aligos Therapeutics, Inc. (CIK 1799448)